NUMA1 and breast cancer: The AUC of NMP22 for the diagnosis of BC was 0.650 (0.548-0.743), 0.698 (0.589-0.792) with a sensitivity of 42%, 48.84% and a specificity of 88%, 90.7% in the training and validation cohort, respectively (Figure S1).